Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

2023 Will See A Grant of €130 Million To The WHO By Germany

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Biotech Innovation Strengthening Clinical Pipelines

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.

Precision Diagnostics Accelerating Early Detection

The fundamental strategy of clinical medicine is shifting from managing symptoms to identifying the earliest molecular indicators of disease. By integrating sophisticated genomic analysis with high-fidelity imaging, practitioners are now able to intercept pathological processes long before they manifest as systemic illness, significantly improving the efficacy of therapeutic interventions.

UK Medical Device Testing Jumps 17%,...

Clinical investigations of medical devices in the UK reached...

Following Germany’s health minister Karl Lauterbach’s meeting with the UN health agency’s head on February 2, it has been decided that Germany will pledge 130 million euros to the World Health Organization this year. As per the data from WHO, this announcement did not make it return to the top spot in terms of donation after Berlin, even though temporarily had overtaken the major historical contributor, Washington, in the last funding period, i.e., between 2020 and 2021, because of the Trump-era funding cuts.

As per what Karl Lauterbach had to say to the reporters following a meeting with WHO Director-General Tedros Adhanom Ghebreyesus at the Geneva headquarters, they are happy to go ahead and pledge 130 million euros this year to WHO. He added on his official twitter handle that it is imperative WHO gets financially strengthened so that one is better equipped to fight the next pandemic.

The minister met the WHO Director-General on the sidelines of the executive board meeting of the top healthcare body, which happens to be seeking reinforcement when it comes to global health but is still unsure on how to do it. The World Health Organization’s funding system has a gap of $1 billion and is widely seen as wanting to go through a much-needed reform considering its over-reliance on donors.

Speaking on Berlin’s latest contribution, Tedros said that they do appreciate its strategic support. Apparently, Germany was one of the countries that helped Tedros, who hails from Ethiopia, get re-elected to a second term. The country has already contributed $776 million as per the latest findings against $1.12 billion which has been contributed by the United States, as per the WHO data. These figures, however, do not include the latest announcement on the funds.

Latest stories

Related stories

Biotech Innovation Strengthening Clinical Pipelines

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.

Precision Diagnostics Accelerating Early Detection

The fundamental strategy of clinical medicine is shifting from managing symptoms to identifying the earliest molecular indicators of disease. By integrating sophisticated genomic analysis with high-fidelity imaging, practitioners are now able to intercept pathological processes long before they manifest as systemic illness, significantly improving the efficacy of therapeutic interventions.

UK Medical Device Testing Jumps 17%, AI and Neurotech Lead

Clinical investigations of medical devices in the UK reached...

Medtronic Secures FDA PMA for Infuse Bone Graft in TLIF

Medtronic announced that it has secured FDA premarket approval...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »